CTL‐TIL lines have been developed from tumour infiltrating lymphocytes (TIL) from the ascites of patients with ovarian carcinoma, and used to investigate whether common tumour antigens are expressed on allogeneic ovarian tumours epithelial tumour lines derived from colon and pancreatic carcinoma. Three CTL lines expressed preferential cytolytic activity against autologous tumour cells and against certain allogeneic ovarian tumour cells that shared HLA‐A2 molecules. Analysis of the target specificity of these CTL lines indicated that they also lysed human colon and pancreatic tumour lines sharing HLA‐A2. CTL‐TIL clones isolated from these lines were found to lyse HLA‐A2+ ovarian, colon and pancreatic tumours, and to recognize clonally distributed common epitopes on pancreas and colon tumour clones. These results indicate that shared tumour antigens can he found among tumours of common epithelial cell origin. These results indicate a novel class of T‐cell‐definable tumour antigens recognized by tumour‐reactive CTL on human tumours and may be significant for understanding of cellular immunity in ovarian cancer, identification of CTL‐defined tumour antigens and future adoptive specific immunotherapeutic approaches in ovarian cancer.
|Original language||English (US)|
|Number of pages||12|
|Journal||Scandinavian Journal of Immunology|
|State||Published - Apr 1993|
ASJC Scopus subject areas